| Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an Italian hospital G Arcari, G Raponi, F Sacco, G Bibbolino, FM Di Lella, F Alessandri, ... International journal of antimicrobial agents 57 (1), 106245, 2021 | 61 | 2021 |
| Evolutionary trajectories toward ceftazidime-avibactam resistance in Klebsiella pneumoniae clinical isolates A Carattoli, G Arcari, G Bibbolino, F Sacco, D Tomolillo, FM Di Lella, ... Antimicrobial Agents and Chemotherapy 65 (10), 10.1128/aac. 00574-21, 2021 | 58 | 2021 |
| Cefiderocol for compassionate use in the treatment of complicated infections caused by extensively and pan-resistant Acinetobacter baumannii A Oliva, G Ceccarelli, M De Angelis, F Sacco, MC Miele, CM Mastroianni, ... Journal of Global Antimicrobial Resistance 23, 292-296, 2020 | 52 | 2020 |
| Clinical impact of COVID-19 on multi-drug-resistant gram-negative bacilli bloodstream infections in an intensive care unit setting: two pandemics compared F Cogliati Dezza, G Arcari, F Alessi, S Valeri, A Curtolo, F Sacco, ... Antibiotics 11 (7), 926, 2022 | 25 | 2022 |
| Iodine deficiency in Italy A Rapa, D Marinello, E Chiorboli, F Sacco, G Bona The Lancet 354 (9178), 596-597, 1999 | 23 | 1999 |
| The Antimicrobial Peptide Esc(1-21) Synergizes with Colistin in Inhibiting the Growth and in Killing Multidrug Resistant Acinetobacter baumannii Strains F Sacco, C Bitossi, B Casciaro, MR Loffredo, G Fabiano, L Torrini, ... Antibiotics 11 (2), 234, 2022 | 15 | 2022 |
| Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem: a case report G Arcari, A Oliva, F Sacco, FM Di Lella, G Raponi, D Tomolillo, A Curtolo, ... European Journal of Clinical Microbiology & Infectious Diseases 41 (3), 495-500, 2022 | 11 | 2022 |
| Disseminated fungal infection due to Saprochaete clavata in a kidney transplant recipient P Pavone, A Oliva, G Raponi, F Pugliese, S Martelli, P Celli, F Sacco, ... Journal De Mycologie Medicale 29 (3), 278-281, 2019 | 11 | 2019 |
| Corporate heritage communication strategies of iconic Italian brands: a multiple case study F Sacco, E Conz Corporate Communications: An International Journal 28 (7), 19-43, 2023 | 10 | 2023 |
| Genome-Based Retrospective Analysis of a Providencia stuartii Outbreak in Rome, Italy: Broad Spectrum IncC Plasmids Spread the NDM Carbapenemase within … V Capitani, G Arcari, A Oliva, F Sacco, G Menichincheri, L Fenske, ... Antibiotics 12 (5), 943, 2023 | 9 | 2023 |
| Risk factors for carbapenem-resistant Acinetobacter baumannii (CRAB) bloodstream infections and related mortality in critically ill patients with CRAB colonization F Cogliati Dezza, S Covino, F Petrucci, F Sacco, A Viscido, F Gavaruzzi, ... JAC-Antimicrobial Resistance 5 (4), dlad096, 2023 | 6 | 2023 |
| Clinical Characteristics and Outcome of Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae Carbapenemase–Producing Klebsiella pneumoniae Infections … A Oliva, L Campogiani, G Savelloni, P Vitale, A Lodi, F Sacco, A Imeneo, ... Open Forum Infectious Diseases 10 (7), ofad327, 2023 | 6 | 2023 |
| Genotypic evolution of Klebsiella pneumoniae sequence type 512 during ceftazidime/avibactam, meropenem/vaborbactam, and cefiderocol treatment, Italy G Arcari, F Cecilia, A Oliva, R Polani, G Raponi, F Sacco, A De Francesco, ... Emerging Infectious Diseases 29 (11), 2266, 2023 | 5 | 2023 |
| Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: analysis of cases and evaluation of in vitro activity of fosfomycin-containing … A Oliva, D Al Ismail, G Arcari, MC Miele, E Casali, F Sacco, L Volpicelli, ... Journal of Global Antimicrobial Resistance 33, 321-327, 2023 | 5 | 2023 |
| Sepsis caused by Haemophilus influenzae type B with septic arthritis in an infant G Bona, F Cadario, E Benevenuta, F Sacco, E Garzoli, R Passaro Minerva Pediatrica 50 (5), 193-196, 1998 | 5 | 1998 |
| Urinary iodine excretion (UIE) screening in newborn exposed to iodine-containing antiseptic. A Rapa, E Chiorboli, C Corbetta, F Sacco, G Bona, L Silvestro, M Zaffaroni, ... Hormone Research 46, 74--, 1996 | 5 | 1996 |
| Cefiderocol for compassionate use in the treatment of complicated infections caused by extensively and pan-resistant Acinetobacter baumannii. J Glob Antimicrob Resist. 2020; 23 … A Oliva, G Ceccarelli, M De Angelis, F Sacco, MC Miele, CM Mastroianni, ... | 5 | |
| An outbreak sustained by ST15 Klebsiella pneumoniae carrying 16S rRNA methyltransferases and blaNDM: evaluation of the global dissemination of these resistance determinants F Sacco, G Raponi, A Oliva, G Bibbolino, V Mauro, FM Di Lella, ... International Journal of Antimicrobial Agents 60 (2), 106615, 2022 | 4 | 2022 |
| Chemical exposure in Cultural Heritage restoration: questionnaire to define the state of art. A Macchia, F Sacco, S Morello, F Prestileo, FM La Russa, S Ruffolo, ... SCIENZA E BENI CULTURALI 30, 529-540, 2014 | 4 | 2014 |
| Rejuvenating business models via startup collaborations: Evidence from the Turkish context P Buyukbalci, F Sanguineti, F Sacco Journal of Business Research 174, 114521, 2024 | 3 | 2024 |
